- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, Aerotech Inc., a global leader in precision motion control and automation, launched the HexGen HEX150-125HL miniature hexapod motion platform, a six degree of freedom (DOF) precision positioning system. This compact and cost-effective hexapod sports platform has a base diameter of 150 millimeters and a nominal height of 125 millimeters. It can achieve a minimum incremental movement of up...
According to reports, a research team at the University of Chicago in the United States recently demonstrated a new method for obtaining mid infrared emission using colloidal quantum dots (QDs), which may open up new applications for mid infrared light sources.Colloidal quantum dots are a type of semiconductor nanocrystal material that provides a promising approach for the synthesis of light sourc...
Recently, Swiss company Bystronic disclosed its financial performance for the first half of 2024.The financial report shows that the market situation for the Swiss Super 100 in the first half of 2024 remains very tense. Customers in various end markets are unable to fully utilize their production capacity, and operations in all regions are relatively cautious.Despite Swiss supercar actively reduci...
A muffler is a key component of a car's exhaust system, designed to reduce noise levels and emissions. The vibration of a muffler can have a significant impact on its performance and life. In order to understand the performance and behavior of the muffler, it is necessary to make multi-point vibration measurement. First, it enables engineers to assess the structural integrity and durability of a m...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...